14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jun 07, 2019 $119.41 $119.70 $117.18 $118.40 1 439 306
Jun 06, 2019 $119.19 $120.28 $118.52 $118.81 2 003 727
Jun 05, 2019 $118.21 $119.02 $117.11 $118.78 1 339 475
Jun 04, 2019 $115.21 $117.62 $114.69 $117.54 2 045 747
Jun 03, 2019 $113.97 $116.47 $113.31 $114.05 1 815 508
May 31, 2019 $118.56 $118.58 $112.86 $113.68 2 403 343
May 30, 2019 $122.21 $123.13 $119.71 $120.49 1 547 700
May 29, 2019 $124.17 $124.49 $121.03 $121.30 1 382 949
May 28, 2019 $127.00 $127.90 $124.68 $125.00 1 237 649
May 24, 2019 $126.27 $128.26 $125.70 $127.15 973 926
May 23, 2019 $125.86 $126.69 $123.12 $125.33 1 593 589
May 22, 2019 $128.49 $128.96 $125.32 $127.55 1 170 533
May 21, 2019 $128.00 $129.57 $127.44 $128.80 1 127 965
May 20, 2019 $129.70 $129.70 $125.48 $127.23 1 129 645
May 17, 2019 $130.60 $131.99 $129.86 $130.90 1 165 938
May 16, 2019 $128.77 $131.97 $128.45 $131.40 1 303 645
May 15, 2019 $126.86 $129.43 $125.98 $128.41 838 465
May 14, 2019 $126.97 $129.14 $126.22 $127.93 1 033 665
May 13, 2019 $128.68 $129.44 $125.61 $125.92 1 647 992
May 10, 2019 $131.42 $131.96 $127.46 $131.69 1 324 078
May 09, 2019 $132.45 $132.84 $128.62 $131.77 1 297 339
May 08, 2019 $134.42 $135.49 $133.12 $133.65 807 657
May 07, 2019 $135.43 $136.52 $133.03 $134.52 996 990
May 06, 2019 $134.23 $137.52 $132.64 $136.96 752 707
May 03, 2019 $134.00 $136.83 $133.46 $136.69 1 042 121
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT